Afatinib in non-small cell lung cancer

被引：0
|
作者：
Wood, G. E. [1 ]
Polychronis, A. [1 ]
机构：
[1] Mt Vernon Canc Ctr, Med Oncol, Northwood, Middx, England
来源：
LUNG CANCER | 2016年 / 91卷
关键词：
D O I：
10.1016/S0169-5002(16)30080-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
63
引用
收藏
页码：S23 / S23
页数：1
相关论文
共 50 条
  • [41] Non-small cell lung cancer
    M. Dediu
    W. Hilbe
    memo - Magazine of European Medical Oncology, 2008, 1 (4) : 247 - 251
  • [42] ;Non-small cell lung cancer
    Dediu, M.
    Hilbe, W.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2008, 1 (04) : 247 - 251
  • [43] Non-small cell lung cancer
    Adamietz, I. A.
    Niederle, N.
    ONKOLOGE, 2010, 16 (06): : 63 - 74
  • [44] Overcoming Acquired Resistance to Afatinib in HCC827, a Non-small Cell Lung Cancer Cell Line
    Hsu, J.
    Lin, W.
    Lien, T.
    Chang, W.
    Sun, M.
    Jiang, S.
    Yen, K.
    Chao, Y.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 47 - 48
  • [45] Celastrol acts synergistically with afatinib to suppress non-small cell lung cancer cell proliferation by inducing paraptosis
    Dai, Chun-Hau
    Zhu, Li-Rong
    Wang, Yi
    Tang, Xing-Ping
    Du, Yong-Jie
    Chen, Yong-Chang
    Li, Jian
    JOURNAL OF CELLULAR PHYSIOLOGY, 2021, 236 (06) : 4538 - 4554
  • [46] Phase Ib trial of afatinib and BI 836845 in advanced non-small cell lung cancer (NSCLC)
    Tan, D.
    Lin, C. -C.
    Huang, D. Chin-Lun
    Jung, H.
    Bogenrieder, T.
    Park, K.
    ANNALS OF ONCOLOGY, 2015, 26 : 147 - 147
  • [47] Takotsubo cardiomyopathy Afatinib-related in a non-small cell lung cancer patient: Case report
    Ramos, German. E. E.
    Caglevic, Christian
    Bulnes, Juan. F. F.
    Panay, Sergio. E. E.
    Zapata, Mario. I. I.
    Daniele, Andres J.
    Rodriguez, Manuel. E. E.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [48] Dissecting the m6A methylation affection on afatinib resistance in non-small cell lung cancer
    Qianqian Meng
    Shuyuan Wang
    Shunheng Zhou
    Haizhou Liu
    Xueyan Ma
    Xu Zhou
    Hui Liu
    Chaohan Xu
    Wei Jiang
    The Pharmacogenomics Journal, 2020, 20 : 227 - 234
  • [49] Gefitinib and Afatinib Treatment in an Advanced Non-small Cell Lung Cancer (NSCLC) Patient Undergoing Hemodialysis
    Bersanelli, Melissa
    Tiseo, Marcello
    Artioli, Fabrizio
    Lucchi, Leonardo
    Ardizzoni, Andrea
    ANTICANCER RESEARCH, 2014, 34 (06) : 3185 - 3188
  • [50] Management of toxicities and dose reduction/interruption of afatinib for EGFR mutated non-small cell lung cancer
    Hirai, Fumihiko
    Shimamatsu, Shinichiro
    Toyokawa, Gouji
    Yoshida, Tsukihisa
    Nosaki, Kaname
    Yamaguchi, Masafumi
    Seto, Takashi
    Takenoyama, Mitsuhiro
    Ichinose, Yukito
    ANNALS OF ONCOLOGY, 2015, 26 : 137 - 137
12345